Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin

Author(s):
Baranski, Z.; Jong, Y. de; Ilkova, T.; Peterse, E.F.P.; Cleton-Jansen, A.M.; Water, B. van de; Hogendoorn, P.C.W. (0000-0002-1513-8104); Bovee, J.V.M.G. (0000-0003-1155-0481); Danen, E.H.J.
Published
2015
Publication type
Article / Letter to editor
osteosarcomaapoptosisautophagyBcl-xLdoxorubicin
Date issued
2015-11-03
Language
English
Is part of
Oncotarget (2015), Vol. 6, no. 34, p. 36113-36125
hdl
1887/107254